Cargando…
Serological diagnosis of myasthenia gravis and its clinical significance
Myasthenia gravis (MG) is the most common immune-mediated disorder of the neuromuscular junction. Anti-acetylcholine receptor (anti-AChR), anti-muscle-specific kinase (anti-MuSK), and anti-lipoprotein receptor-related protein 4 (anti-LRP4) antibodies are the three well-defined pathogenic antibodies....
Autores principales: | Li, Yi, Peng, Yuyao, Yang, Huan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116419/ https://www.ncbi.nlm.nih.gov/pubmed/37090043 http://dx.doi.org/10.21037/atm-19-363 |
Ejemplares similares
-
Diagnosis of Myasthenia Gravis
por: Rousseff, Rossen T.
Publicado: (2021) -
Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis
por: Kwon, Young Nam, et al.
Publicado: (2022) -
Factors affecting minimal manifestation status induction in myasthenia gravis
por: Li, Yi, et al.
Publicado: (2022) -
Tacrolimus as Single-Agent Immunotherapy and Minimal Manifestation Status in Nonthymoma Myasthenia Gravis
por: Duan, Weiwei, et al.
Publicado: (2021) -
Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)